| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |